Built upon proprietary technology, Chitogen provides high performance hemostatic products to rapidly stop bleeding. Chitogen has U.S. FDA 510(k) clearances for its range of SoftSeal®-STF Hemostatic Pads. Clinical studies have been very positive, with a high level of provider satisfaction. Chitogen’s range of products include SoftSeal®-STF, which is used in femoral procedures, SoftSeal®-STFR, ideal for radial procedures and D-Seal®, a hemostatic pad designed specifically for the hemodialysis market. Additionally, Chitogen is in early trial development for a patented combination product for the trauma wound care market, including emergency and military applications.